Treatment for depressive disorders

Abstract

The present invention provides a method for treating a depressive disorder which comprises a dministering a melatonin agonist alone, or in combination wit additional ant idepressant medication(s). The depressive disorder treated is one or more of major depression, dysthymia or bipolar disorder. A kit is also provided com prising one or more pharmaceutical dose units of a melatonin agonist and oneor more pharmaceutical dose units of an antidepressant. The individual dose .units may each further comprise an antidepressant or antipsychotic, and opt ionally one or more pharmaceutically active ingredients.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of co-pending US Provisional Patent Application Serial No. 60 / 747,843, filed May 22, 2006, which is hereby incorporated into this application. technical field [0003] The present invention belongs to the field of drug treatment of depressive diseases. Background technique [0004] Depressive disorders affect nearly 20 million adults in the United States alone. Depressive disorders can be emotionally and physically debilitating if left untreated. [0005] Depressive disorders include a spectrum of symptoms listed in a brochure published by the U.S. National Institute of Mental Health (NIMH) entitled "Depression" as follows: [0006] "Persistent sadness, anxiety, or 'empty' feelings [0007] despair, pessimism [0008] Guilt, worthlessness, helplessness [0009] Loss of interest or pleasure in hobbies and activities (including sex) that you once enjoyed [0010] Decreased energy...

AI Technical Summary

Problems solved by technology

[0019] A less severe type of depression, dysthymia, involves long-term chronic symptoms that do not cause incapacity but prevent the sufferer from being able to function well or feel well

Images